Compare QNCX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | SEVN |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 147.2M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | SEVN |
|---|---|---|
| Price | $3.80 | $9.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $7.75 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.1M | 177.1K |
| Earning Date | 11-12-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 11.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $29,408,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $8.30 |
| 52 Week High | $4.55 | $13.97 |
| Indicator | QNCX | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 56.76 |
| Support Level | $3.74 | $8.30 |
| Resistance Level | $4.55 | $9.81 |
| Average True Range (ATR) | 0.46 | 0.22 |
| MACD | 0.05 | 0.14 |
| Stochastic Oscillator | 64.39 | 67.55 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.